{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:11:42Z","timestamp":1774447902744,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ard.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:51:30Z","timestamp":1745941890000},"page":"888-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Annals of the Rheumatic Diseases collection on axial spondyloarthritis (2022-2024): advances in the field"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8899-9087","authenticated-orcid":false,"given":"Sofia","family":"Ramiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-158X","authenticated-orcid":false,"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.03.005_bib0001","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","article-title":"Axial spondyloarthritis","volume":"80","author":"Navarro-Comp\u00e1n","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0002","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/ard-2022-223428","article-title":"Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis","volume":"82","author":"Chen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0003","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/ard-2022-223791","article-title":"Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis","volume":"82","author":"Tavasolian","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0004","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/ard-2024-226018","article-title":"Altered CD8+ T cell subpopulation in the bone marrow microenvironment of cynomolgus monkeys with spontaneous ankylosing spondylitis","volume":"83","author":"Guan","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard-2023-224107","article-title":"CD_99 G1 neutrophils modulate osteogenic differentiation of mesenchymal stem cells in the pathological process of ankylosing spondylitis","volume":"83","author":"Feng","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0006","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard-2022-223146","article-title":"Card9\/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis","volume":"83","author":"Rosenzweig","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0007","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/ard-2023-224434","article-title":"HLA-B27, axial spondyloarthritis and survival","volume":"82","author":"Li","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0008","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2021-222083","article-title":"Factors predicting axial spondyloarthritis among first-degree relatives of probands with ankylosing spondylitis: a family study spanning 35 years","volume":"81","author":"van der Linden","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0009","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard-2023-224959","article-title":"Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort","volume":"83","author":"Marques","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/ard-2023-225406","article-title":"Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis","volume":"83","author":"Kim","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0011","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1136\/ard-2024-226587","article-title":"Correspondence on \u2018Risk of cardiovascular disease with high-dose versus low-dose use of non-steroidal anti-inflammatory drugs in ankylosing spondylitis\u2019 by Kim et al","volume":"83","author":"Landew\u00e9","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0012","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/ard-2022-222641","article-title":"Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)","volume":"81","author":"Meissner","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0013","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/annrheumdis-2021-220136","article-title":"Choose wisely: imaging for diagnosis of axial spondyloarthritis","volume":"81","author":"Diekhoff","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0014","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/ard-2022-222986","article-title":"Diagnostic evaluation of the sacroiliac joints for axial spondyloarthritis: should MRI replace radiography?","volume":"81","author":"Poddubnyy","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/ard-2024-225862","article-title":"Performance analysis of a deep-learning algorithm to detect the presence of inflammation in MRI of sacroiliac joints in patients with axial spondyloarthritis","volume":"84","author":"Nicolaes","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0016","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2021-222081","article-title":"MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group","volume":"81","author":"Baraliakos","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0017","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/ard-2023-225184","article-title":"Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort","volume":"83","author":"Molto","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0018","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-019-0819-8","article-title":"The European map of axial spondyloarthritis: capturing the patient perspective-an analysis of 2846 patients across 13 countries","volume":"21","author":"Garrido-Cumbrera","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ard.2025.03.005_bib0019","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/ard-2022-222796","article-title":"Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis","volume":"82","author":"Nam","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/annrheumdis-2021-221406","article-title":"Significance of structural changes in the sacroiliac joints of patients with axial spondyloarthritis detected by MRI related to patients symptoms and functioning","volume":"81","author":"Braun","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-017-1453-3","article-title":"Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort","volume":"19","author":"Protopopov","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ard.2025.03.005_bib0022","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/ard-2023-225444","article-title":"MRI-based synthetic CT: a new method for structural damage assessment in the spine in patients with axial spondyloarthritis\u2014a comparison with low-dose CT and radiography","volume":"83","author":"Willesen","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0023","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/ard-2022-223297","article-title":"Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis","volume":"82","author":"Ortolan","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0024","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/ard-2022-223298","article-title":"Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis","volume":"82","author":"Webers","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/annrheumdis-2021-221001","article-title":"Fat mass and response to TNF\u03b1 blockers in early axial spondyloarthritis: an analysis of the DESIR cohort","volume":"81","author":"Molto","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0026","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/ard-2022-223595","article-title":"Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials","volume":"82","author":"van der Heijde","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0027","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/ard-2023-224803","article-title":"Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies","volume":"83","author":"Baraliakos","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0028","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/ard-2024-225933","article-title":"Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b\/3 trials","volume":"83","author":"Brown","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0029","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1136\/ard-2022-222608","article-title":"Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial","volume":"81","author":"van der Heijde","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0030","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/annrheumdis-2022-222260","article-title":"Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial","volume":"81","author":"Michielsens","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0031","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard-2022-222731","article-title":"Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study","volume":"82","author":"Landew\u00e9","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0032","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/ard-2023-224699","volume":"83","author":"Proft","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0033","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/annrheumdis-2022-222324","article-title":"Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis","volume":"81","author":"Torgutalp","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0036","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/ard-2023-225185","article-title":"Goodbye to the term \u2018ankylosing spondylitis\u2019, hello \u2018axial spondyloarthritis\u2019: time to embrace the ASAS-defined nomenclature","volume":"83","author":"van der Heijde","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0037","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/annrheumdis-2022-222747","article-title":"Instrument selection for the ASAS core outcome set for axial spondyloarthritis","volume":"82","author":"Navarro-Comp\u00e1n","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0038","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard-2023-224232","article-title":"ASAS consensus definition of early axial spondyloarthritis","volume":"83","author":"Navarro-Comp\u00e1n","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.005_bib0039","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/ard-2024-226280","article-title":"Clinical information on imaging referrals for suspected or known axial spondyloarthritis: recommendations from the Assessment of Spondyloarthritis International Society (ASAS)","volume":"83","author":"Diekhoff","year":"2024","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:11:18Z","timestamp":1774415478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725008246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0003496725008246"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.03.005","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Annals of the Rheumatic Diseases collection on axial spondyloarthritis (2022-2024): advances in the field","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}